IPO

Saroja Pharma Industries India Limited IPO

NSE SME

Listed On: Sep 13, 2023 at ₹ 65.0

₹ 268800 /3200 Shares
*Min Investment

Check Allotment

31 Aug, 2023

Open Date

05 Sep, 2023

Close Date

11 Sep, 2023

Allotment Date

13 Sep, 2023

Listing Date
Saroja Pharma Industries India Limited IPO Issue Details
  • Issue Price ₹84 per equity share
  • Face Value ₹10 Per Equity Share
  • Issue Price 1,084,800 shares(aggregating up to ₹9.11 Cr)
  • Listing at NSE SME
  • List Price 65.0
  • Listing Date 2023-09-13
  • Lead Manager Swastika Investmart Ltd
  • Registrar Kfin Technologies Limited
Saroja Pharma Industries India Limited IPO Details
  • Retail Portion 50%
Saroja Pharma Industries India Limited IPO Documents
Saroja Pharma Industries India Limited IPO Details


Saroja Pharma Industries India Limited IPO is an SME IPO, priced at ₹84 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform.

The IPO bidding window is open from Aug 31, 2023 to Sep 5, 2023. The allotment is expected to be finalized on Sep 11, 2023, and the tentative listing date is Sep 13, 2023.


The registrar of the IPO is Kfin Technologies Limited, and

Read More
Saroja Pharma Industries India Limited IPO Subscription Analysis And Details
Retail
14.65x
Total
8.79x
As onQIB / NIIRetailTotal
Shares Offered / Reserved515,200515,2001,030,400
Day 1 31-08-23 06:00 PM
0.11 x1.58 x0.79 x
Day 2 01-09-23 06:00 PM
0.49 x3.75 x2.12 x
Day 3 04-09-23 06:00 PM
1.14 x7.62 x4.39 x
Day 4 05-09-23 06:00 PM
2.90 x14.65 x8.79 x
Saroja Pharma Industries India Limited Valuations
Earnings Per Share (EPS) ₹3.61/-
P/E Ratio 23.27
RoNW 20.85%
Net Asset Value (NAV) - Post Issue ₹N/A/-
Saroja Pharma Industries India Limited Company Financials
In Lakhs
In Lakh
31-Mar-2331-Mar-2231-Mar-21
Assets2,133.991,551.19822.39
Revenue5,035.095,595.673,674.67
Profit After Tax106.06114.0173.13
About Saroja Pharma Industries India Limited Company

Saroja Pharma Industries India Limited is engaged in trading, exporting and supplying Specialty Chemicals & API.

The company deals in three types of product categories:

1. Chemical, 2. Pharma Intermediary and 3. Veterinary Pharma API. The company supplies products such as Liquide Bromine, which is used as an agro-intermediate, Ethyl Acetate, which is used as an API solvent, and other pharmaceuticals used for human and veterinary drugs, and some of them are API solvents.

APIs, known as bulk drugs or bulk actives, are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid or other forms of dosage, with the addition of other APIs or inactive ingredients.

The company exports products mainly in Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore etc.

Read More
Saroja Pharma Industries India Limited - Promoter(s)

Mr. Biju Gopinathan Nair

Mr. Manish Dasharath Kamble

Pre Issue Share Holding : 100%

Post Issue Share Holding : 73.02%

Saroja Pharma Industries India Limited IPO - Issue Objectives
1

To Set-up a Manufacturing Unit.

2

To Repay the Unsecured Loans.

3

Public Issue Expenses.